Pemoline therapy in college students with attention deficit hyperactivity disorder: A retrospective study

Journal of the American College Health Association

Volumn 45, Issue 1, 1996, Pages 35-39

  Heiligenstein, Eric ^a,b   Johnston, Hugh F ^a   Nielsen, Julie K ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b The University Health Services   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Attention deficit hyperactivity disorder; Pemoline; Psychostimulants; Student health services

Indexed keywords

DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; METHYLPHENIDATE; PEMOLINE;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; COLLEGE STUDENT; DISEASE SEVERITY; DRUG ABUSE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSOMNIA; MALE; MINIMAL BRAIN DYSFUNCTION; SCORING SYSTEM;

EID: 0029901964     PISSN: 07448481     EISSN: None     Source Type: Journal    
DOI: 10.1080/07448481.1996.9937543     Document Type: Article

References (26)

1. Barkley, R. A., Fischer, M., Edelbrock, C. S., and Smallish, L., 1990. The adolescent outcome of hyperactive children diagnosed by research criteria I:An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry, 29:546–557.
2. Klein, R. G., and Mannuzza, S., 1991. Long-term outcome of hyperactive children:A review. J Am Acad Child Adolesc Psychiatry, 30:383–387.
3. Mannuzza, S., Klein, R. G., Bonagura, N., Malloy, P., Giampino, T. L., and Addalli, K. A., 1991. Hyperactive boys almost grown up V:Replication of psychiatric status. Arch Gen Psychiatry, 48:77–83.
4. Zametkin, A. J., 1995. Attention deficit disorder:Born to be hyperactive?. JAMA, 273:1871–1874.
5. Weiss, G., Hechtman, L., Milroy, T., and Perlman, T., 1985. Psychiatric status of hyperactives as adults:A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry, 24:211–220.
6. Biederman, J., Faraone, S. V., Spencer, T., 1993. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry, 150:1792–1798.
7. Klein, R. G., and Mannuzza, S., 1989. “ The long-term outcome of attention deficit disorder/hyperkinetic syndrome ”. In Attention Deficit Disorder:Clinical and Basic Research, Edited by:Sagvolden, T., and Archer, T., 71–89. Hillside, NJ:Erlbaum.
8. Heiligenstein, E., and Keeling, R. P., 1995. Presentation of unrecognized attention deficit hyperactivity disorder in college students. J Am Coll Health, 5:226–228.
9. Greenhill, L. L., 1992. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatr Clin North Am., 15:1–27.
10. Abikoff, H., and Gittelman, R., 1985. Hyperactive children treated with stimulants:Is cognitive training a useful adjunct?. Arch Gen Psychiatry, 42:953–961.
11. Klein, R. G., 1987. “ Pharmacotherapy of childhood hyperactivity:An update ”. In Psychopharmacology:The Third Generation of Progress, Edited by:Meltzer, H. Y., 1215–1224. New York:Raven.
12. Wood, D. R., Reimherr, F. W., Wender, P. W., and Johnson, G. E., 1976. Diagnosis and treatment of minimal brain dysfunction in adults:A preliminary report. Arch Gen Psychiatry, 33:1453–1460.
13. Wender, P. H., Reimherr, F. W., Wood, D., and Ward, M., 1985. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry, 142:547–552.
14. Mattes, J. A., Boswell, L., and Oliver, H., 1984. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry, 41:1059–1063.
15. Gualtieri, C. T., Ondrusek, M. G., and Finley, C., 1985. Attention deficit disorders in adults. Clin Neuoropharmacol., 8:343–356.
16. Wender, P. H., Reimherr, F. W., and Wood, D. R., 1981. Attention deficit disorder (“minimal brain dysfunction”) in adults. Arch Gen Psychiatry, 38:449–456.
17. Spencer, T., Wilens, T., Biederman, J., Faraone, S. V., Ablon, S., and Lapey, K., 1995. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry, 52:434–443.
18. Eisenberg, L., 1966. The management of the hyperkinetic child. Dev Med Child Neurol., 8:593–632.
19. Sallee, F. R., Stiller, R. L., and Perel, J. M., 1992. Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry, 31:224–251.
20. 1987. Diagnostic and Statistical Manual of Mental Disorders:DSM III-R., 3rd ed rev., Washington, DC:American Psychiatric Association.
21. Barkley, R. A., 1990. Attention Deficit Hyperactivity Disorder:A Handbook for Diagnosis and Treatment, New York:Guilford.
22. Brown, T. E., and Gammon, G. D., Attention-activation disorders in high IQ underachievers. Meeting Abstracts. Washington, DC:American Academy of Child and Adolescent Psychiatry.
23. Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology, Rev ed., DHEW-ADM 76–388 217–222. National Institutes of Health, National Institute of Mental Health.
24. National Institute of Mental Health. 1985. Clinical global impressions. Psychopharmacol Bull., 21:839–843.
25. Nehra, A., Mullick, F., Ishak, K. G., and Zimmerman, H. J., 1990. Pemoline-associated hepatic injury. Gastroenterology, 99:1517–1519.
26. Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M., 1990. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder:A comparison of standard methylphenidate, sustained-release methylphenidate, sustained release dextroamphetamine, and pemoline. Pediatrics, 86:226–237.